// App-Quantinova.ai

: Post-Operative Dialysis in Failing Fontan Patients Undergoing Heart Transplant How Well Does the Pre-Transplant Creatinine Clearance Risk-Stratify Patients?

Researchers

Presenter

  • Humera Ahmed

Principal Investigators

  • John Dykes

  • Sharon Chen

  • Maryanne Chrisant

  • Kevin P Daly

  • Rebecca K Ameduri

  • Kenneth R Knecht

  • Marc Richmond

  • Marc E Richmond

  • Kimberly Y Lin

  • Simon Urschel

  • Jacob Simmonds

  • KATHLEEN SIMPSON

  • Kurt Schumacher

  • Christopher S Almond

Medical Centers

  • UNIV MINNESOTA, Minneapolis, MN

  • CHILDRENS HOSPITAL BOSTON, Boston, MA

  • JOE DIMAGGIO CHILDREN HOSPITAL, Hollywood, FL

  • COLUMBIA UNIV, New York, NY

  • Stollery Children's Hosp Univ of Alberta, Canada

  • Stanford Univ, Palo Alto, CA

  • Stanford Univ, Palo Alto, CA

  • Univ of Arkansas for Med Sci, Little Rock, AR

  • UNIVERSITY OF MICHIGAN, Ann arbor, MI, USA

  • Great Ormond Street Hosp, London

  • Seattle Children's, Seattle, WA

  • CHOP, Philadelphia, PA

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Fontan failure

  • Heart muscle disease

  • Lhermitte-Duclos disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved